Form 4: AbbVie Director Frederick H. Waddell Reports Acquisition and Disposal of Shares

Director Frederick H. Waddell reports changes in beneficial ownership of AbbVie Inc. shares, including the acquisition of restricted stock units and disposal of shares.

Summary

• Frederick H. Waddell, a director of AbbVie Inc., filed a Form 4 with the SEC.
• The filing reports changes in his beneficial ownership of AbbVie common stock.
• On May 9, 2025, Waddell acquired 1,203 restricted stock units (RSUs) under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These RSUs will be paid in shares of AbbVie common stock on a one-to-one basis upon separation from service, death, or a change in control.
• Waddell also disposed of 28,958 shares.
• Following these transactions, Waddell directly owns 28,958 shares of AbbVie common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units will be paid out in shares of AbbVie common stock upon the earlier of the director's separation from service, death, or a change in control.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies like AbbVie. It provides transparency to investors regarding the actions of company leadership.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the stock transactions of a company director.

Key Dates

Keywords

Form 4, Beneficial Ownership, AbbVie, ABBV, Director, Frederick H. Waddell, Restricted Stock Units, RSU, Incentive Stock Program, Shares